BusinessAI imageTyra, Nasus, Bionano, Tenaya Biotech Stocks Rise on Key Developments
Tyra Biosciences, Nasus Pharma, Bionano Genomics, and Tenaya Therapeutics saw gains in Monday trading. Tyra secured $400 million financing, Nasus received FDA clearance for its NS002 epinephrine powder, Bionano released new peer-reviewed OGM data, and Tenaya obtained FDA RMAT designation for its TN-401 gene therapy candidate.
Rttnews·


